GEODE CAPITAL MANAGEMENT, LLC
Position in PHAT — Phathom Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in PHAT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,754,579
-$3,053,690 QoQ
Shares Held
1,328,045
+23.7% QoQ
Ownership
1.67%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PHAT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,550,967,073 across 528 Biotechnology names. PHAT ranks #139 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in PHAT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,754,579 | 1,328,045 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $17,808,269 | 1,073,434 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $12,816,470 | 1,088,910 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $10,260,599 | 1,069,927 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $6,372,971 | 1,016,423 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $8,270,178 | 1,018,495 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $15,601,557 | 862,918 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $8,302,283 | 806,047 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $7,979,644 | 751,379 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,713,042 | 735,273 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,078,250 | 682,570 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,018,561 | 490,123 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,203,082 | 448,611 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,881,193 | 435,044 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,457,395 | 402,292 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,928,139 | 346,936 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,271,049 | 313,817 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,767,204 | 293,198 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $9,112,002 | 283,863 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $9,524,476 | 281,373 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $7,869,120 | 209,508 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $5,895,686 | 177,474 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,659,235 | 181,599 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,869,235 | 178,342 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $4,155,135 | 160,927 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||